Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanaji T Talele

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Plos One|December 19, 2013
Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1)Eduardo E Chufan, Khyati Kapoor, Hong-May Sim, et al.
Biochemical and Biophysical Research Communications|December 25, 2015
Discovery of conjugated thiazolidinone-thiadiazole scaffold as anti-dengue virus polymerase inhibitorsDinesh Manvar, İlkay Küçükgüzel, Gizem Erensoy, et al.
Marine Drugs|July 1, 2014
Lamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp., reverses BCRP mediated drug resistance in cancer cellsXiao-Cong Huang, Xue Xiao, Yun-Kai Zhang, et al.
Journal of Medicinal Chemistry|December 19, 2017
Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-GlycoproteinBhargav A Patel, Biebele Abel, Anna Maria Barbuti, et al.
European Journal of Medicinal Chemistry|October 29, 2013
2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymeraseIlkay Küçükgüzel, Gökhan Satılmış, K R Gurukumar, et al.
Scientific Reports|May 10, 2016
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transportersYun-Kai Zhang, Guan-Nan Zhang, Yi-Jun Wang, et al.
The Biochemical Journal|February 19, 2024
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaksUday Kiran Velagapudi, Élise Rouleau-Turcotte, Ramya Billur, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 14, 2015
Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazolesPelin Çıkla-Süzgün, Neerja Kaushik-Basu, Amartya Basu, et al.
Biochemical Pharmacology|February 26, 2014
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivoKamlesh Sodani, Atish Patel, Nagaraju Anreddy, et al.
Biochemistry|August 2, 2011
The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocketNootan Pandey, Chaturbhuj A Mishra, Dinesh Manvar, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Plos One|December 19, 2013
Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1)Eduardo E Chufan, Khyati Kapoor, Hong-May Sim, et al.
Biochemical and Biophysical Research Communications|December 25, 2015
Discovery of conjugated thiazolidinone-thiadiazole scaffold as anti-dengue virus polymerase inhibitorsDinesh Manvar, İlkay Küçükgüzel, Gizem Erensoy, et al.
Marine Drugs|July 1, 2014
Lamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp., reverses BCRP mediated drug resistance in cancer cellsXiao-Cong Huang, Xue Xiao, Yun-Kai Zhang, et al.
Journal of Medicinal Chemistry|December 19, 2017
Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-GlycoproteinBhargav A Patel, Biebele Abel, Anna Maria Barbuti, et al.
European Journal of Medicinal Chemistry|October 29, 2013
2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymeraseIlkay Küçükgüzel, Gökhan Satılmış, K R Gurukumar, et al.
Scientific Reports|May 10, 2016
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transportersYun-Kai Zhang, Guan-Nan Zhang, Yi-Jun Wang, et al.
The Biochemical Journal|February 19, 2024
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaksUday Kiran Velagapudi, Élise Rouleau-Turcotte, Ramya Billur, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 14, 2015
Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazolesPelin Çıkla-Süzgün, Neerja Kaushik-Basu, Amartya Basu, et al.
Biochemical Pharmacology|February 26, 2014
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivoKamlesh Sodani, Atish Patel, Nagaraju Anreddy, et al.
Biochemistry|August 2, 2011
The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocketNootan Pandey, Chaturbhuj A Mishra, Dinesh Manvar, et al.
Pageof 10